MNPR — Monopar Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $11.17m
- $3.91m
Annual cashflow statement for Monopar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.22 | -6.3 | -9.1 | -10.5 | -8.4 |
| Non-Cash Items | 1.01 | 1.2 | 1.47 | 1.64 | 1.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.196 | 0.444 | 0.318 | 1.65 | -1.35 |
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -3.02 | -4.66 | -7.32 | -7.23 | -7.86 |
| Other Investing Cash Flow Items | — | — | — | -4.92 | 4.93 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | — | -4.92 | 4.93 |
| Financing Cash Flow Items | -0.985 | -0.116 | -0.063 | -0.077 | -0.047 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.35 | 8.18 | 10.9 | 0.033 | 2.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.32 | 3.52 | 3.57 | -12.1 | -0.92 |